Oxford BioMedica (OTCMKTS:OXBDF) Trading Up 2.6% – Still a Buy?

Oxford BioMedica (OTCMKTS:OXBDFGet Free Report) shares were up 2.6% during trading on Thursday . The company traded as high as $4.82 and last traded at $4.77. Approximately 7,507 shares traded hands during trading, an increase of 1,150% from the average daily volume of 600 shares. The stock had previously closed at $4.65.

Oxford BioMedica Stock Up 2.6%

The business has a 50 day moving average price of $4.27 and a two-hundred day moving average price of $4.36.

Oxford BioMedica Company Profile

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Recommended Stories

Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.